Monthly Archives: April 2013

… AND ANOTHER OFFICIAL APPROVAL … TBDx™ to be Evaluated in Uganda as Front-End Screening Technology for Liquid Culture

The Internal Review Board for the Joint Clinical Research Centre (JCRC) in Kampala, Uganda recently approved a protocol to study and evaluate TBDx™ and the use of automated sputum microscopy as part of a larger bi-directional study assessing predictive links between … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , , , , , ,

Government of Nigeria to Clinically Evaluate TBDx™ in June

Tuberculosis is a major public health problem in Nigeria, and the country is 4th among the 22 countries with the highest TB burden worldwide.  The World Health Organization estimates incident and prevalence rates for all forms of TB of 118 … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , , , , , | 2 Comments

Opportunity Awaits TBDx in South Africa

The team leaves Wednesday for Johannesburg, South Africa for an important evaluation of our TBDx technology that has been in the planning stages for the past several months.  The evaluation will take place at the National Health Laboratory Services (NHLS) … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , ,